Neogen Corp Dossier
Qualitative Analysis
Business overview
Neogen Corporation (NASDAQ: NEOG) is a leading global developer, manufacturer, and marketer of products dedicated to food and animal safety. The company operates through two primary segments: Food Safety and Animal Safety. The Food Safety segment provides diagnostic test kits and culture media to detect pathogens, allergens, drug residues, and sanitation concerns in food processing and agricultural environments. The Animal Safety segment offers veterinary instruments, pharmaceuticals, vaccines, biosecurity products, and genomics testing services designed to improve livestock health and breeding traits. Neogen's business model sits at the critical intersection of global protein consumption, supply chain integrity, and agricultural productivity.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Transitioning the manufacturing of Petrifilm products to in-house facilities to mitigate supply chain risks and improve gross margins.
Expected impact: Elimination of duplicative manufacturing costs and sequential improvement in operating margins.
Realigning commercial resources to higher-return markets, establishing unified solutions-based selling standards globally, and enhancing performance rigor through metric-based analysis.
Expected impact: Strengthened sales and marketing engine to drive organic growth and stabilize core business segments.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Neogen entered into a definitive agreement to sell its global genomics business (GeneSeek) to Zoetis for $160 million. This allows Neogen to simplify its business, focus on core food and animal safety markets, and accelerate de-leveraging.
Terms: Transaction value of $160 million in cash, with expected net proceeds of approximately $140 million to be used primarily for debt reduction.